Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is unchanged from the same period last year.
Company Anticipates Stability and Growth to Positively Impact Real Estate SectorMIAMI, FL / ACCESSWIRE / April 22, 2024 / Gaucho Group Holdings, Inc. (NASDAQ:VINO), a company that includes a growing collection of